Conclusion: Significance was approached for TMA (p ¼ 0.055) suggesting that increasing the sample size could possibly generate statistically significant results. However, further analysis of this population is required to assess the exact impact of decreased skeletal muscle and visceral fat area in patient survival outcomes and post-treatment complications. Policy of full disclosure: None. Figure 1. SliceOmatic image (Gold-TMA, Yellow-SFA, Red-VFA). P-05-015 PENILE PRIMARY MELANOMA. CASE REPORT. de Verdonces, L. 1 ; Hannaoui, N. 2 ; Martos, R. 2 ; Ballester, R. 2 ; Fadil, Y. 2 ; Capdevila, M. 2 ; Parejo, V. 2 ; Rosado, M. 2 ; Muñoz, J. 2 ; Garcia, D. 2 ; Abad, C. 2 ; Prats, J. 2 1 Hospital Parc Tauli Sabadell, Urology, Spain; 2 Hospital Parc Tauli Sabadell, Spain Objective: To present a case of an uncommon penile cancer. The primary melanoma of the glans or male urethra is rare and it is associated with a poor prognosis. It accounts <0.1% of all mel- anomas and represents less than 1.4% of all malignant lesions of the penis. Methods: A 37-year-old man was referred to dermatologist for evaluation of a pigmented lesion of the penis. It appeared 2 years ago, increasing in size in the last months. The physical examination showed a macular lesion on the glans, that was hyperpigmented and crusty, with irregular borders, 2x1.5cm in size, and affected the balanopreputial fold and frenulum. In addition, he had 2 small proximal satellite lesions and bilateral pathological palpable lymphadenopathy. A punch biopsy was performed to confirm the suspected diagnosis of melanoma. In a multidisciplinary assessment with urologists, dermatologists and oncologists, the patient was considered candidate for an organ-preserving surgical procedure. Then, with a radical intention, a partial penectomy (with a wide security margin of 3cm) and bilateral inguinal lymphadenec- tomy was performed. Results: The postoperative course was uneventful and the pa- tient preserved his sexual function. He has spontaneous erections although he does not practice sexual relations because a depres- sive disorder secondary to his disease and treatment. Conclusion: Only a few data of penile melanoma is published and for this reason the development and standardization of a therapeutic protocol is difficult. Despite a radical surgical treat- ment and the emergence of new adjuvant therapies, penile melanoma with lymph node involvement has a poor prognosis, with survival of 30% at 5 years approximately. Policy of full disclosure: None. Figure 1. Penile melanoma. P-05-016 MALIGNANT PRIAPISM AND NON UROLOGIC PRIMITIVE TUMORS ARE RELATED WITH THE POORER PROGNOSIS IN MEN WITH PENILE METASTASES: RESULTS OF A SYSTEMATIC REVIEW Cocci, A. 1 ; Gacci, M. 1 ; Cai, T. 2 ; Nesi, G. 1 ; Seni, S. 1 ; Carini, M. 1 1 University of Florence, Italy; 2 Santa Chiara Hospital, Trento, Italy Objective: Metastases to the penis from other cancers are rare but can have severe consequences. Usually, penile metastasis signifies a poor prognosis but little else is known. The aim of this study is to systematically review all available literature on penile metastatic disease in order to gain more information on the presentation and prognosis of this manifestation of metastatic disease. Methods: We reviewed the literature relating to all case reports, series and reviews about penile metastasis through a systematic Medline search. We identified 63 articles and 69 patients with an age range of 57 to 92 years and a mean follow up of 15.6 months (range 5-30). Results: Metastases were located on the root (38.8%), the shaft (38.8%) or the glans (22.4%) of the penis. In most cases the diagnosis of penile metastasis was made after the primary cancer had been diagnosed. A single small penile nodule was the most common presentation. 30 patients with urological metastasis J Sex Med 2016;13:S216eS226 S222 P-05 Late Breaking Posters - MSD Downloaded from https://academic.oup.com/jsm/article/13/Supplement_2/S222/7017271 by guest on 03 February 2023